Talniflumate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C21H13F3N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JFK78S0U9S, chemically known as 3-pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, 1,3-dihydro-3-oxo-1-isobenzofuranyl ester but generally known as talniflumate, which bears US NIH Compound Identifier 48229. European Medicines Agency schedules Talniflumate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10810MIG. The term TALNIFLUMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). TALNIFLUMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule talniflumate under HS 29349990 and SITC 51579. As of Q4 2014, TALNIFLUMATE remains the US FDA Preferred Term for this commodity. Talniflumate bears US NLM identifiers UMLS ID C0772080 and NCI Concept Code C73096. SMILES: FC(F)(F)C1CC(NC2NCCCC2C(=O)OC2OC(=O)C3C2CCCC3)CCC1.